How to address sexuality with a couple?

Christine Reynaert(1), Thomas Dubois(1), Marcello Di Gregorio(2), Nathalie Michaux(3) Published in the journal : September 2018 Category : Congrès de médecine sexuelle

Working with the couple is of real interest in many medical situations, and particularly in the field of sexology. This article highlights the benefits of working with the couple, proposes different communication strategies, and comes to the conclusion that working in the relational system of patients is part of medical practice.

Read more

How to address sexuality with a woman during medical consultation?

Nathalie Michaux(1), Maria-Laura Marotta(2), Marcelo Di Gregorio(3), Christine Reynaert(4) Published in the journal : September 2018 Category : Congrès de médecine sexuelle

This article explains in a very concrete way how to approach sexuality with a female patient during a consultation, irrespective of the medical specialty.

Read more

How to address sexuality with a man?

Marcelo Di Gregorio MD1, Francis Lorge MD(1), Christine Reynaert MD(2), Nathalie Michaux MD(3) Published in the journal : September 2018 Category : Congrès de médecine sexuelle

a sexological consultation is a delicate task that requires a specific approach. The first difficulty in managing a sexual problem is to get the issue on the table. Patients visit their physician because of problems concerning sexuality/ sexual activity and their consequences. The question is whether general practitioners prefer to avoid answering these questions or if they are willing to respond actively. If so, to what extent are they able to answer the patient’s question? And would they agree to attend specific training courses and to work in collaboration with specialists within a network system. This work’s aim was to provide tools for acquiring and mastering specific medical knowledge and practical skills regarding male sexual disorders (erectile dysfunction, ejaculation and libido disorders) and to facilitate the acquisition of communication skills for the consultation (doctor / patient relationship). 

Read more

Treatment adherence in cardiovascular prevention : the lipidologist's point of view

Olivier S. Descamps Published in the journal : September 2018 Category : GRAPA

The "sneaky" aspect of the risk associated with high blood cholesterol given its asymptomatic nature before complications arise makes hypolipidemic treatment often problematic for our patients. This is especially so because the side effects that can occur such as myalgia and the polemics diffused through the media by some critics cause worry and doubts in our patients. In this article, we will discuss three of the most frequently encountered problems and how to address them.

Read more

Guselkumab, an effective interleukin-23 inhibitor in the treatment of psoriasis

Caroline Colmant, Pierre-Dominique Ghislain (1) Published in the journal : September 2018 Category : Actualité thérapeutique

Guselkumab is a selective interleukin-23 inhibitor that has been marketed and reimbursed since a few months in Belgium. We conducted a literature review in order to assess the efficacy and safety of guselkumab.

Read more

News from the GRAPA (task force for the prevention of atherothrombosis) 9th GRAPA symposium (3rd March 2018)

Alexandre Persu Published in the journal : September 2018 Category : GRAPA

The news from the GRAPA provide a summary of the presentations made at the 9th GRAPA symposium, with a focus on treatment adherence in the prevention of cardiovascular diseases, mainly in the areas of lipidology, diabetology, and rhythmology. The presentations also addressed related topics, such as therapeutic inertia, therapeutic education, empowerment, and the impact of treatment-related adverse events and media controversies on the initiation and continuation of cardiovascular medications. Finally, arguments for the control of cardiovascular risk factors in the prevention of atrial fibrillation, based on recent medical literature, are also presented. 

Read more

Treatment of hemophilia A: Which role for plasmaderived factor VIII in 2018?

Cédric Hermans Published in the journal : September 2018 Category : Actualité thérapeutique

After thousands of hemophilic patients were infected with HIV and HCV, and thanks to major advances in biotechnology, recombinant factor VIII has emerged as a first-line or reference treatment for most factor VIII-deficient patients (hemophilia A). The development of neutralizing antibodies (inhibitors) is currently the most severe and feared complication in hemophilia A replacement therapy. The respective immunogenicity of plasma and recombinant factor VIII concentrates has been debated for many years, with multiple studies providing contradictory results.

Read more


Martin Buysschaert Published in the journal : September 2018 Category : Diabétologie

Xultophy® is a new combination product consisting of basal insulin (degludec) and a GLP-1 agonist (liraglutide). In this article, we analyzed recent literature in order to find out its potential advantages in general and compared to basal insulin in particular, as well as to clarify its role in the therapeutic management of insulinrequiring type 2 diabetes. 

Read more

Comparison of tacrolimus plus induction via intraoperative single high-dose of rabbit anti-T-lymphocyte globulins versus tacrolimus monotherapy in adult liver transplantation: 1-year results of an investigator-driven randomized controlled trial

Kevin Ackenine(1), Samuele Iesari1, (2), Maxime Foguenne(1), Chantal De Reyck(1), Eliano Bonaccorsi Riani(1), Olga Ciccarelli(1), Laurent Coubeau(1), Quirino Lai(3), Mina Komuta(4), Pierre Gianello(5), Jan Lerut(1) Published in the journal : July 2018 Category : Mémoires de Recherche Clinique

The efficacy of anti-lymphocyte serum (ALS) induction remains inconclusive in liver transplantation (LT) due to poorly designed trials.

Read more

Acute liver failure in children: experience of a paediatric intensive care unit

Valentine Hermans(1), Thierry Detaille(1), Astrid Haenecour(1), Emilien Derycke(1), Laurent Houtekie(1), Raymond Reding(2), Stéphan Clément de Cléty(1) Published in the journal : July 2018 Category : Mémoires de Recherche Clinique

Pediatric acute liver failure (PALF) is a rare yet severe condition characterized by rapidly progressing hepatic dysfunction and multisystem organ failure (MOF) syndrome in previously healthy children. It poses several clinical challenges to physicians, one of them being the identification of the children who won’t recover without liver transplantation (LT).

Read more